James Vollins - 22 Mar 2022 Form 4 Insider Report for BIODELIVERY SCIENCES INTERNATIONAL INC

Reporting relationship: General Counsel, Chief Compliance Officer & Corporate Secretary
Issuer ticker: N/A
Reported as of: 22 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Mar 2022, 17:18:09 UTC
Prior SEC filing: 08 Feb 2022
Next SEC filing: 14 Apr 2023
Source filing: View source filing
Reporting owner signature: /s/ James Vollins

Key filing fact

James Vollins filed Form 4 for BIODELIVERY SCIENCES INTERNATIONAL INC on 22 Mar 2022.

Key facts

This page summarizes James Vollins's Form 4 filing for BIODELIVERY SCIENCES INTERNATIONAL INC.
6 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 22 Mar 2022, 17:18.

Change

Previous filing in this sequence was filed on 08 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BDSI transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value: $0
Shares: -91,401
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 91,401
Exercise price: $0.000000
Footnotes: F1, F2

BDSI transaction Derivative

Stock Options (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -29,826
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 29,826
Exercise price: $3.46
Footnotes: F3

BDSI transaction Derivative

Stock Options (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -43,334
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 43,334
Exercise price: $3.90
Footnotes: F3

BDSI transaction Derivative

Stock Options (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -269,244
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 269,244
Exercise price: $3.84
Footnotes: F3

BDSI transaction Derivative

Stock Options (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -82,508
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 82,508
Exercise price: $3.03
Footnotes: F3

BDSI transaction Derivative

Stock Options (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -282,055
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 282,055
Exercise price: $3.66
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

James Vollins is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents the contingent right to receive one Share.

Footnote F2

Each Issuer RSUs that was outstanding immediately prior to the Effective Time, was cancelled and converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the Merger Consideration.

Footnote F3

Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an "In-the-Money Cash Out Option") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration.

SEC remarks

General Counsel, Chief Compliance Officer & Corporate Secretary